Exhibit D. Example of Section 3 (amounts and definitions for TrOOP and total drug costs) for a plan that offers Supplemental Drug Coverage
NOTE: The page that follows has a fictional example of Section 3 from the draft revised Model Part D EOB; it is for a fictional plan that offers Supplemental Drug Coverage. Using numbers from 2020 for illustration, this section gives amounts and definitions of out-of-pocket costs and total drug costs.
The main purpose of Section 3 is to give the definitions. The monthly and year-to-date totals for a member’s out-of-pocket costs and total drug costs have already been given at the end of Chart 1 in Section 1 (Section 1 is the list of prescriptions filled during the month).
We’re including this Section to help you keep track of your “out-of-pocket costs” and “total drug costs” because these costs determine which drug payment stage you are in. As explained in Section 2, the payment stage you are in determines how much you pay for your prescriptions.
Your “out-of-pocket costs” |
Your “total drug costs” |
|
$310.60 month of September, 2020$4,356.00 year-to-date (since January, 2020) (This total includes $312.50 in out-of-pocket costs from when you were in a different plan earlier this year.) |
$453.84 month of September, 2020 $6,244.34 year-to-date (since January, 2020) (This total includes $600.50 in total drug costs from when you were in a different plan earlier this year.) |
|
DEFINITION:“Out of pocket costs” includes:
It does not include:
|
DEFINITION:“Total drug costs” is the total of all payments made for your covered Part D drugs. It includes:
NOTE: Our plan offers Supplemental Drug Coverage for some drugs not generally covered by Medicare. If you have filled any prescriptions for these drugs this month, they are listed in a separate chart (Chart 2) in Section 1. The amounts paid for these drugs do not count toward your out-of-pocket costs or total drug costs. |
Learn more. Medicare has made the rules about which types of payments count and do not count toward “out-of-pocket costs” and “total drug costs.” The definitions on this page give you only the main rules. For details, including more about “covered Part D drugs,” see the Evidence of Coverage, our benefits booklet (for more about the Evidence of Coverage, see Section 6).
PRA Disclosure Statement According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this collection is 0938-0964. The time required to complete this information collection is estimated to average 200 hours per response based on the time and effort necessary to disclose and disseminate plan information and materials. If you have any comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to CMS, 7500 Security Boulevard, Attn: PRA Reports Clearance Officer, Baltimore, Maryland 21244-1850.
CMS does not discriminate in its programs and activities: To request this form in an accessible format (e.g., Braille, Large Print, Audio CD) contact your Medicare Drug Plan. If you need assistance contacting your plan, call: 1-800-MEDICARE.
Form CMS-10141 OMB Control No. 0938-0964 (Expires 11/30/2021)
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Jeanne McGee |
File Modified | 0000-00-00 |
File Created | 2021-01-15 |